DiaSorin revenue and financials
€77.90Change from previous close: +1.25%Absolute change: +€0.96
In the fiscal year ended December 2025, DiaSorin reported revenue of €1.2B (+0.81% year over year). Net income was €155.62M, a net margin of 13.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +0.81%
- 2025 vs 2024
- Net income growth
- −17.27%
- 2025 vs 2024
- Net margin
- 13.0%
- 2024: 15.9%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 343 | 359 | 312 | 389 | — |
| Depreciation and amortization | 128 | 129 | 137 | 153 | — |
| Capital expenditure | -138 | -120 | -113 | -114 | — |
| Investing cash flow | -145 | -49.8 | -29.1 | -232 | — |
| Financing cash flow | -351 | -259 | -236 | -333 | — |
| Dividends paid | -63.5 | -61.3 | -59.0 | -57.1 | — |
| Effect of exchange rates | -25.5 | 14.1 | -8.1 | 14.4 | — |
| Net change in cash | -153 | 49.8 | 46.6 | -176 | — |
| Free cash flow | 205 | 239 | 198 | 276 | — |